Reports

Sale

Molecular Diagnostics Market

Global Molecular Diagnostics Market Size, Share, Growth: By Product & Service: Instruments, Reagents & Kits, Services & Software; By Test Location: Point-of-Care, Self-test or Over the Counter, Central Laboratories; By Technology; By Application; By End User; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032

Global Molecular Diagnostics Market Size

The global molecular diagnostics market was valued at USD 20.573 billion in 2023, driven by rising innovation in molecular diagnostic technologies and their widespread application across the globe. The market is expected to grow at a CAGR of 8.2% during the forecast period of 2024-2032, with the values likely to reach USD 40.922 billion by 2032.

 

Global Molecular Diagnostics Market Outlook

  • Infectious diseases are ranked as one of the leading causes of mortality and morbidity globally, accounting for around 33% of deaths every year. As a result, infectious diseases dominate the market share based on therapeutic areas.
  • One of the major market trends is the continuous advancement and innovation in molecular diagnostic technologies supported by intensive research efforts and substantial investment activities.
  • The market share is influenced by the increasing adoption of digital PCR assays with automated and multiplexed capabilities and its rising integration in point-of-care settings.

 

Global Molecular Diagnostics Market Overview

Molecular diagnostics are laboratory techniques used to analyze biological markers in the genome and proteome to help detect a disease or the risk of developing a disease. It involves studying DNA and RNA to analyze and identify caution points that indicate the potential emergence of a specific disease. The rising prevalence of infectious diseases and growing cancer cases are the major factors impacting the market demand. Moreover, the market growth is driven by increasing significant advancements in molecular diagnostic technologies (such as next-generation sequencing (NGS), polymerase chain reaction, and microarrays), the growing demand for personalized medicine, and favorable regulatory policies that accelerate the approval of new molecular diagnostic tests.

 

Global Molecular Diagnostics Market Growth Drivers

Continuous Advancements in Molecular Diagnostic Technologies Support Market Growth

 

The market is further expected to experience continuous advancements and innovation to enhance the existing molecular diagnostic technologies such as nucleic acid detection in various diagnostic settings in the early detection of diseases. For instance, Changchun Liu, professor of Biomedical Engineering at UConn Health, has developed a new method that improves existing diagnostic technology for a more rapid, sensitive, and deployable approach to molecular diagnostics. The research discovered new potential for simple and sensitive nucleic acid detection in various diagnostic settings, including early cancer diagnostics and infectious disease detection using new and improved clustered regularly interspaced short palindromic repeats (CRISPR) technology. Such research efforts aimed at improving the capabilities of molecular diagnostic tests are expected to elevate the market value in the forecast period.

 

Strategic Collaborations to Meet Rising Molecular Diagnostics Market Demand

The market for molecular diagnostics is one of the fastest-growing markets in the healthcare sector. The increasing awareness about the potential of early diagnosis and personalized medicine/treatments is collectively contributing to the market growth. For instance, in January 2023, Alveo signed a Memorandum of Understanding (MOU) with the Barbados Investment and Development Corporation (Export Barbados (BIDC)) to co-develop its novel molecular sensing platform, while contributing to the growth of the life sciences industry in the Caribbean nation. Such collaborations are anticipated to expand the market reach while sharing assets to co-develop novel solutions in the molecular diagnostics market.

 

Global Molecular Diagnostics Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

 

Trend     Impact
Growing Emphasis on Personalized Medicine The rising emphasis on personalized medicine is significantly influencing the demand for molecular diagnostics, as these technologies facilitate the identification of individual genetic profiles that can guide targeted treatment approaches. This trend is expanding the use of molecular diagnostics in routine medical practices, improving patient outcomes, and impacting the development of targeted therapies.
Rising Demand for Point-of-Care Testing The expansion of point-of-care (POC) testing is making molecular diagnostics more accessible and convenient. Such tests can be used in non-laboratory environments such as clinics and homes. This allows rapid diagnosis and treatment, which is particularly crucial in managing infectious diseases and during health emergencies like the COVID-19 pandemic. The rising patient inclination towards POC molecular tests is expected to augment molecular diagnostics market demand.
Increasing Application in Oncology Molecular diagnostics are increasingly used in oncology for early detection and monitoring. The rising collaborations between research institutions and diagnostic companies also increase the demand for advanced molecular diagnostics. This trend is poised to facilitate the development of new cancer diagnostics, aiding in early and more precise cancer detection needed for effective treatment.
Favorable Regulatory Policies Supportive government policies and faster regulatory approvals for molecular diagnostic tests are essential for the rapid introduction of innovative molecular diagnostic tests in clinical settings. This not only helps in responding swiftly to public health challenges but also encourages investment and innovation within the molecular diagnostics sector, further fueling the market expansion.

 

Global Molecular Diagnostics Market Segmentation

Market Breakup by Product & Service

  • Instruments
  • Reagents & Kits
  • Services & Software

 

Market Breakup by Test Location

  • Point-of-Care
  • Self-test or Over the Counter
  • Central Laboratories

 

Market Breakup by Technology

  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Chips and Microarrays
  • Mass Spectrometry
  • Sequencing
  • Transcription Mediated Amplification
  • Others

 

Market Breakup by Application

  • Oncology
    • Breast Cancer
    • Colorectal Cancer
    • Lung Cancer
    • Prostate Cancer
    • Other Cancers
  • Pharmacogenomics
  • Infectious Diseases
    • Hepatitis
    • HIV
    • CT/NG
    • Hospital Acquired Infections (HAI)
    • HPV
    • Tuberculosis
    • Influenza
    • Other Infectious Diseases
  • Genetic Testing
  • Neurological Diseases
  • Cardiovascular Diseases
  • Microbiology
  • Others

 

Market Breakup by End User

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Other End Users

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Global Molecular Diagnostics Market Share

Market Segmentation Based on Application is Poised to Witness Substantial Growth

 

Based on application, the market oncology (breast cancer, colorectal cancer, lung cancer, prostate cancer, other cancers), pharmacogenomics, infectious diseases (hepatitis, HIV, CT/NG, hospital acquired infections (HAI), HPV, tuberculosis, influenza, other infectious diseases), genetic testing, neurological diseases, cardiovascular diseases, and microbiology, among others.

 

The infectious disease segment is valued at USD 9.399 billion in 2023, dominating the application market segment. Infectious diseases are ranked as one of the leading causes of mortality and morbidity globally, accounting for around 33% of deaths every year. Additionally, it is reported that almost half of the world’s population is considered at risk of emerging and re-emerging infectious diseases. Thus, the rising burden of infectious diseases propels the demand for effective molecular diagnostic solutions to facilitate early detection and appropriate interventions. Consequently, this will lead to increased molecular diagnostics market demand.

 

Polymerase Chain Reaction Technology to Lead the Market Share Based on Technology

 

The market segmentation by technologies includes polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), chips and microarrays, mass spectrometry, sequencing, and transcription mediated amplification, among others.

 

Polymerase chain reaction leads the segment, with the market size expected to rise from USD 16.083 billion in 2024 to USD 29.832 billion in 2032. The increasing adoption of digital PCR assays with automated and multiplexed capabilities is influencing the market dynamics. Additionally, the integration of PCR technologies in point-of-care settings and the surge in the introduction of advanced PCR products are contributing to its growing market presence.

 

Global Molecular Diagnostics Market Analysis by Region

Based on the geographic analysis of the market, North America, particularly, the United States dominates the regional market with the market size valued at USD 13.061 billion in 2023. The rising prevalence of infectious diseases and growing preference for personalized medicine are some of the key factors likely to drive the market growth during the forecast period.

 

Further, the increasing research and development activities are also boosting the market share in the region. For instance, in July 2023 , a group of researchers at Queensland University of Technology (QUT) developed a new approach for designing molecular ON-OFF switches based on proteins with widespread application in biotechnological, biomedical, and bioengineering. The research team mentioned that this novel approach will enable them to develop diagnostic tests for the early detection of diseases that are designed and built faster and with more accuracy. Such developments are anticipated to propel advancements in molecular diagnostic methods, thereby elevating the market value.

 

molecular diagnostics market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Leading Players in the Global Molecular Diagnostics Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • BioMérieux SA
  • BD (Becton, Dickinson and Company)
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Agilent Technologies, Inc.
  • Hologic Inc.
  • Danaher Corporation
  • DiaSorin
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc.
  • QIAGEN N.V.
  • F. Hoffmann-La Roche, Ltd.
  • PerkinElmer, Inc.
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product & Service
  • Test Location
  • Technology
  • Application
  • End User
  • Region
Breakup by Product & Service
  • Instruments
  • Reagents & Kits
  • Services & Software
Breakup by Test Location
  • Point-of-Care
  • Self-test or Over the Counter
  • Central Laboratories
Breakup by Technology
  • Polymerase Chain Reaction (PCR) 
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Chips and Microarrays
  • Mass Spectrometry
  • Sequencing
  • Transcription Mediated Amplification
  • Others
Breakup by Application
  • Oncology
  • Pharmacogenomics
  • Infectious Diseases
  • Genetic Testing
  • Neurological Diseases
  • Cardiovascular Diseases
  • Microbiology
  • Others
Breakup by End User
  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Other End Users
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • BioMérieux SA
  • BD
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Agilent Technologies, Inc.
  • Hologic Inc.
  • Danaher Corporation
  • DiaSorin
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc.
  • QIAGEN N.V.
  • F. Hoffmann-La Roche, Ltd.
  • PerkinElmer, Inc.
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.

 

Key Questions Answered in the Global Molecular Diagnostics Market Report

  • What was the global molecular diagnostics market value in 2023?
  • What is the global molecular diagnostics market forecast outlook for 2024-2032?
  • What are the regional markets covered in the EMR report?
  • What is market segmentation based on products and services?
  • What is the market breakup based on test location?
  • Who are the major end users in the market?
  • What types of technologies are present in the market?
  • Where does molecular diagnostics find its application?
  • What are the major factors boosting the global molecular diagnostics market size? 
  • How has the molecular diagnostics market performed so far and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints? 
  • Which regional market is expected to lead the market share in the forecast period? 
  • Which country is expected to experience expedited growth during the forecast period? 
  • How does the prevalence and incidence of infectious diseases affect the market landscape?
  • How does the rise in the aging population impact the market size?
  • Which product & service will dominate the market share? 
  • Which application area is expected to have a high market value in the coming years?
  • Which technology type will experience the highest demand in the market segment?
  • What are the major global molecular diagnostics market trends?
  • Who are the key players involved in the market?
  • Which end user is poised to elevate the market value?
  • Which test location covers a major market share?
  • What is the patent landscape of the market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Molecular Diagnostics Market Overview 

    3.1    Global Molecular Diagnostics Market Historical Value (2017-2023) 
    3.2    Global Molecular Diagnostics Market Forecast Value (2024-2032)
4    Global Molecular Diagnostics Market Landscape
    4.1    Global Molecular Diagnostics: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Type
        4.1.3    Analysis by Indication
    4.2    Global Molecular Diagnostics: Product Landscape
        4.2.1    Analysis by Product & Service
        4.2.2    Analysis by Technology 
        4.2.3    Analysis by Application 
5    Global Molecular Diagnostics Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
        5.2.1    Strengths
        5.2.2    Weaknesses
        5.2.3    Opportunities
        5.2.4    Threats
    5.3    Porter’s Five Forces Model
        5.3.1    Bargaining Power of Suppliers
        5.3.2    Bargaining Power of Buyers
        5.3.3    Threat of New Entrants
        5.3.4    Threat of Substitutes
        5.3.5    Degree of Rivalry
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Molecular Diagnostics Market Segmentation (2017-2032)
    6.1    Global Molecular Diagnostics Market (2017-2032) by Product & Service
        6.1.1    Market Overview
        6.1.2    Instruments
        6.1.3    Reagents & Kits
        6.1.4    Services & Software
    6.2    Global Molecular Diagnostics Market (2017-2032) by Test Location
        6.2.1    Market Overview
        6.2.2    Point-of-Care
        6.2.3    Self-test or Over the Counter
        6.2.4    Central Laboratories
    6.3    Global Molecular Diagnostics Market (2017-2032) by Technology
        6.3.1    Market Overview
        6.3.2    Polymerase Chain Reaction (PCR) 
        6.3.3    In Situ Hybridization
        6.3.4    Isothermal Nucleic Acid Amplification Technology (INAAT)
        6.3.5    Chips and Microarrays
        6.3.6    Mass Spectrometry
        6.3.7    Sequencing
        6.3.8    Transcription Mediated Amplification
        6.3.9    Others
    6.4    Global Molecular Diagnostics Market (2017-2032) by Application
        6.4.1    Market Overview
        6.4.2    Oncology
            6.4.2.1    Breast Cancer
            6.4.2.2    Colorectal Cancer
            6.4.2.3    Lung Cancer
            6.4.2.4    Prostate Cancer
            6.4.2.5    Other Cancers
        6.4.3    Pharmacogenomics
        6.4.4    Infectious Diseases
            6.4.4.1    Hepatitis
            6.4.4.2    HIV
            6.4.4.3    CT/NG
            6.4.4.4    Hospital Acquired Infections (HAI)
            6.4.4.5    HPV
            6.4.4.6    Tuberculosis
            6.4.4.7    Influenza
            6.4.4.8    Other Infectious Diseases
        6.4.5    Genetic Testing
        6.4.6    Neurological Diseases
        6.4.7    Cardiovascular Diseases
        6.4.8    Microbiology
        6.4.9    Others
    6.5    Global Molecular Diagnostics Market (2017-2032) by End User
        6.5.1    Market Overview
        6.5.2    Diagnostic Laboratories
        6.5.3    Hospitals & Clinics
        6.5.4    Other End Users
    6.6    Global Molecular Diagnostics Market (2017-2032) by Region
        6.6.1    Market Overview
        6.6.2    North America
        6.6.3    Europe 
        6.6.4    Asia Pacific
        6.6.5    Latin America
        6.6.6    Middle East and Africa
7    North America Molecular Diagnostics Market (2017-2032)
    7.1    North America Molecular Diagnostics Market (2017-2032) by Product and Service 
        7.1.1    Market Overview    
        7.1.1    Instruments
        7.1.2    Reagents & Kits
        7.1.3    Services & Software 
    7.2    North America Molecular Diagnostics Market (2017-2032) by Technology
        7.2.1    Market Overview
        7.2.2    Polymerase Chain Reaction (PCR) 
        7.2.3    In Situ Hybridization
        7.2.4    Isothermal Nucleic Acid Amplification Technology (INAAT)
        7.2.5    Chips and Microarrays
        7.2.6    Mass Spectrometry
        7.2.7    Sequencing
        7.2.8    Transcription Mediated Amplification
        7.2.9    Others
    7.3    North America Molecular Diagnostics Market (2017-2032) by Country
        7.3.1    United States of America
        7.3.2    Canada
8    Europe Molecular Diagnostics Market (2017-2032)
    8.1    Europe Molecular Diagnostics Market (2017-2032) by Product and Service
        8.1.1    Market Overview    
        8.1.2    Instruments
        8.1.3    Reagents & Kits
        8.1.4    Services & Software 
    8.2    Europe Molecular Diagnostics Market (2017-2032) by Technology
        8.2.1    Market Overview
        8.2.2    Polymerase Chain Reaction (PCR) 
        8.2.3    In Situ Hybridization
        8.2.4    Isothermal Nucleic Acid Amplification Technology (INAAT)
        8.2.5    Chips and Microarrays
        8.2.6    Mass Spectrometry
        8.2.7    Sequencing
        8.2.8    Transcription Mediated Amplification
        8.2.9    Others
    8.3    Europe Molecular Diagnostics Market (2017-2032) by Country
        8.3.1    United Kingdom
        8.3.2    Germany
        8.3.3    France
        8.3.4    Italy
        8.3.5    Others
9    Asia Pacific Molecular  Diagnostics Market (2017-2032)
    9.1    Asia Pacific Molecular Diagnostics Market (2017-2032) by Product and Service
        9.1.1    Market Overview    
        9.1.2    Instruments
        9.1.3    Reagents & Kits
        9.1.4    Services & Software 
    9.2    Asia Pacific Molecular Diagnostics Market (2017-2032) by Technology
        9.2.1    Market Overview
        9.2.2    Polymerase Chain Reaction (PCR) 
        9.2.3    In Situ Hybridization
        9.2.4    Isothermal Nucleic Acid Amplification Technology (INAAT)
        9.2.5    Chips and Microarrays
        9.2.6    Mass Spectrometry
        9.2.7    Sequencing
        9.2.8    Transcription Mediated Amplification
        9.2.9    Others
    9.3    Asia Pacific Molecular Diagnostics Market (2017-2032) by Country
        9.3.1    China
        9.3.2    Japan
        9.3.3    India
        9.3.4    ASEAN
        9.3.5    Australia
        9.3.6    Others
10    Latin America Molecular Diagnostics Market (2017-2032)
    10.1     Latin America Molecular Diagnostics Market (2017-2032) by Product and Service
        10.1.1    Market Overview    
        10.1.2    Instruments
        10.1.3    Reagents & Kits
        10.1.4    Services & Software 
    10.2    Latin America Molecular Diagnostics Market (2017-2032) by Technology
        10.2.1    Market Overview
        10.2.2    Polymerase Chain Reaction (PCR) 
        10.2.3    In Situ Hybridization
        10.2.4    Isothermal Nucleic Acid Amplification Technology (INAAT)
        10.2.5    Chips and Microarrays
        10.2.6    Mass Spectrometry
        10.2.7    Sequencing
        10.2.8    Transcription Mediated Amplification
        10.2.9    Others
    10.3    Latin America Molecular Diagnostics Market (2017-2032) by Country
        10.3.1    Brazil
        10.3.2    Argentina
        10.3.3    Mexico
        10.3.4    Others
11    Middle East and Africa  Molecular Diagnostics Market (2017-2032)
    11.1    Middle East and Africa Molecular Diagnostics Market (2017-2032) by Product and Service
        11.1.1    Market Overview    
        11.1.2    Instruments
        11.1.3    Reagents & Kits
        11.1.4    Services & Software 
    11.2    Middle East and Africa Molecular Diagnostics Market (2017-2032) by Technology
        11.2.1    Market Overview
        11.2.2    Polymerase Chain Reaction (PCR) 
        11.2.3    In Situ Hybridization
        11.2.4    Isothermal Nucleic Acid Amplification Technology (INAAT)
        11.2.5    Chips and Microarrays
        11.2.6    Mass Spectrometry
        11.2.7    Sequencing
        11.2.8    Transcription Mediated Amplification
        11.2.9    Others
    11.3    Middle East and Africa Molecular Diagnostics Market (2017-2032) by Country
        11.3.1    Saudi Arabia
        11.3.2    United Arab Emirates
        11.3.3    Nigeria
        11.3.4    South Africa
        11.3.5    Others
12    Regulatory Framework
    12.1     Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent  Analysis
    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication Year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by Year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Clinical Trials Analysis
    15.1     Analysis by Trial Registration Year
    15.2    Analysis by Trial Status
    15.3    Analysis by Trial Phase
    15.4    Analysis by Therapeutic Area
    15.5    Analysis by Geography
16    Funding  and Investment Analysis
    16.1    Analysis by Funding Instances
    16.2    Analysis by Type of Funding
    16.3    Analysis by Funding Amount
    16.4    Analysis by Leading Players
    16.5    Analysis by Leading Investors
    16.6    Analysis by Geography
17    Partnership and Collaborations Analysis
    17.1    Analysis by Partnership Instances
    17.2    Analysis by Type of Partnership
    17.3    Analysis by Leading Players
    17.4    Analysis by Geography
18    Supplier Landscape
    18.1    Market Share by Top 5 Companies
    18.2    BioMérieux SA 
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Mergers and Acquisition
        18.2.5    Certifications
    18.3    BD
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Mergers and Acquisition
        18.3.5    Certifications
    18.4    Bio-Rad Laboratories, Inc.
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Mergers and Acquisition
        18.4.5    Certifications
    18.5    Abbott 
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Mergers and Acquisition
        18.5.5    Certifications
    18.6    Agilent Technologies, Inc.
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Mergers and Acquisition
        18.6.5    Certifications
    18.7    Hologic Inc.
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Mergers and Acquisition
        18.7.5    Certifications
    18.8    Danaher Corporation
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Mergers and Acquisition
        18.8.5    Certifications
    18.9    DiaSorin
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Mergers and Acquisition
        18.9.5    Certifications
    18.10    Illumina, Inc.
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Mergers and Acquisition
        18.10.5    Certifications
    18.11    Johnson & Johnson Services, Inc.
        18.11.1    Financial Analysis
        18.11.2    Product Portfolio
        18.11.3    Demographic Reach and Achievements
        18.11.4    Mergers and Acquisition
        18.11.5    Certifications
    18.12    QIAGEN N.V.
        18.12.1    Financial Analysis
        18.12.2    Product Portfolio
        18.12.3    Demographic Reach and Achievements
        18.12.4    Mergers and Acquisition
        18.12.5    Certifications
    18.13    F. Hoffmann-La Roche, Ltd.
        18.13.1    Financial Analysis
        18.13.2    Product Portfolio
        18.13.3    Demographic Reach and Achievements
        18.13.4    Mergers and Acquisition
        18.13.5    Certifications
    18.14    PerkinElmer, Inc.
        18.14.1    Financial Analysis
        18.14.2    Product Portfolio
        18.14.3    Demographic Reach and Achievements
        18.14.4    Mergers and Acquisition
        18.14.5    Certifications
    18.15    Siemens Healthineers
        18.15.1    Financial Analysis
        18.15.2    Product Portfolio
        18.15.3    Demographic Reach and Achievements
        18.15.4    Mergers and Acquisition
        18.15.5    Certifications
    18.16    Thermo Fisher Scientific Inc.
        18.16.1    Financial Analysis
        18.16.2    Product Portfolio
        18.16.3    Demographic Reach and Achievements
        18.16.4    Mergers and Acquisition
        18.16.5    Certifications
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

 

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER